Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

NCT03963193 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

112

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastrointestinal Neuroendocrine Tumor

Interventions

DRUG: Etoposide
DRUG: Irinotecan

Sponsor

Henan Cancer Hospital